Pacemaker rhythm recorded by a cardiac resynchronization device capable of left ventricular sensing.

Suppr

超能文献

作者信息

Barold S Serge, Mello Porto Fernando, Kucher Andreas

机构信息

Florida Heart Rhythm Institute, Tampa, Florida.

出版信息

Pacing Clin Electrophysiol. 2014 Jul;37(7):904-8. doi: 10.1111/pace.12306. Epub 2013 Dec 3.

DOI:10.1111/pace.12306

PMID:24313857

Abstract

摘要

相似文献

Pacemaker rhythm recorded by a cardiac resynchronization device capable of left ventricular sensing.

Pacing Clin Electrophysiol. 2014 Jul;37(7):904-8. doi: 10.1111/pace.12306. Epub 2013 Dec 3.

Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation.

Europace. 2014 Aug;16(8):1205-9. doi: 10.1093/europace/euu050. Epub 2014 Apr 4.

Understanding the timing cycles of a cardiac resynchronization device designed with left ventricular sensing.

Pacing Clin Electrophysiol. 2014 Oct;37(10):1324-37. doi: 10.1111/pace.12496. Epub 2014 Sep 12.

Feasibility, safety, and short-term outcome of leadless ultrasound-based endocardial left ventricular resynchronization in heart failure patients: results of the wireless stimulation endocardially for CRT (WiSE-CRT) study.

Europace. 2014 May;16(5):681-8. doi: 10.1093/europace/eut435. Epub 2014 Feb 4.

Ventricular activation sequence during left ventricular pacing promotes QRS complex oversensing in the atrial channel.

Pacing Clin Electrophysiol. 2011 Dec;34(12):1682-6. doi: 10.1111/j.1540-8159.2011.03219.x. Epub 2011 Sep 28.

Effect of cardiac resynchronization therapy on beat-to-beat T-wave amplitude variability.

Europace. 2012 Nov;14(11):1646-52. doi: 10.1093/europace/eus055. Epub 2012 Mar 15.

Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial.

J Cardiovasc Electrophysiol. 2012 Nov;23(11):1228-36. doi: 10.1111/j.1540-8167.2012.02375.x. Epub 2012 May 31.

Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE).

Circ Arrhythm Electrophysiol. 2013 Dec;6(6):1163-8. doi: 10.1161/CIRCEP.113.000570. Epub 2013 Oct 14.

Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.

Europace. 2013 Oct;15(10):1453-62. doi: 10.1093/europace/eut133. Epub 2013 May 21.

T wave oversensing and low percentage of biventricular pacing in cardiac resynchronization therapy.

Cardiol J. 2009;16(6):580-1.

引用本文的文献

Differentiation of Sinoatrial-like Cardiomyocytes as a Biological Pacemaker Model.

Int J Mol Sci. 2024 Aug 23;25(17):9155. doi: 10.3390/ijms25179155.

Pacemaker-mediated arrhythmias.

J Arrhythm. 2018 Aug 3;34(5):485-492. doi: 10.1002/joa3.12098. eCollection 2018 Oct.

Loss of cardiac resynchronization therapy in a patient with a biventricular implantable cardioverter-defibrillator.

J Arrhythm. 2017 Dec;33(6):652-654. doi: 10.1016/j.joa.2017.08.007. Epub 2017 Sep 30.

Inhibition of left ventricular stimulation due to left ventricular lead failure and the left ventricular T-wave protection algorithm in patient with cardiac resynchronization therapy and pacemaker dependency.

Ann Noninvasive Electrocardiol. 2018 Jan;23(1). doi: 10.1111/anec.12473. Epub 2017 Jun 8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验